The EIT Health Regional Innovation Scheme (RIS) was established in 2015 to provide equal opportunities for next-generation healthcare innovators. Introduced by the European Institute of Innovation and Technology (EIT), it covers regions where the pace of innovation is moderate: from the Baltics, through Central Europe, to Greece, Italy and Portugal.
Today we work with 11 EIT Health Representatives in 11 countries. They act as change agencies that support fast-tracking healthcare entrepreneurs with the skills, network, and resources needed to take their ideas from vision to reality in their regions. EIT Health supports business development at each and every stage to shorten the time-to-market for the most promising projects.
Be the first to find out the latest opportunities with EIT Health. Subscribe to our newsletter.
On this page...
- Programmes
- News
- EIT Health Representatives
What's new?
Fighting Counterfeit Medicines: How Lightly Technologies is Revolutionising Drug Detection
From a university lab to partnering with Interpol,
A system in need of change: why do we need more women leading healthtech innovation?
A growing force of women entrepreneurs is challenging the status quo in healthcare
Unicorns on the horizon: this is how European health innovations can break through
Tamás Békási, RIS Business Creation Lead, discusses start-up success factors with Hungarian Portfolio.
Meet the First Cohort of Start-ups Fast-Tracking Innovation with InnoStars SPICE
Seven pioneering ventures will participate in a one-year programme designed to accelerate their market entry.
Longenesis partners with Novartis to implement a unique digital initiative for proactive heart disease prevention and treatment in Latvia
A digital registry for heart failure and dyslipidemia patients is to improve the quality and timeliness of treatment.
Leading Start-ups from Central, Eastern, and Southern Europe Showcased Their Healthcare Innovations
We know the winners of the InnoStars Grand Final 2024
